AII	angiotensin II
ACEI	angiotensin-converting enzyme inhibitors
ADMA	asymmetric dimethylarginine
AGE	advanced glycation endproducts
ARB	angiotensin receptor blockers
AVP	arginine vasopressin
BNP	B-type natriuretic peptide
CAD	coronary artery disease
CAPD	continuous ambulatory peritoneal dialysis
CHF	chronic heart failure
CKD	chronic kidney disease
CRP	C-reactive protein
CRS	cardiorenal syndrome
CRT	cardiac resynchronization therapy
CVD	cardiovascular disease
EI	endothelin
eGFR	estimated glomerular filtration rate
EPO	erythropoietin
ESA	erythropoiesis-stimulating agents
ESRD	end-stage renal disease
GFR	glomerular filtration rate
HF	heart failure
HFmrEF	heart failure with mildly reduced ejection fraction
HFpEF	heart failure with preserved ejection fraction
HFrEF	heart failure with reduced ejection fraction
Il-1	interleukin 1
Il-6	interleukin 6
KRT	kidney replacement therapy
LVEF	left ventricular ejection fraction
LVH	left ventricular hypertrophy
MLWHFQ	Minnesota Living With Heart Failure Questionnaire
MRAs	mineralocorticoid receptor antagonists
NADH	nicotinamide adenine dinucleotide
NADPH	nicotinamide adenine dinucleotide phosphate
NF-κB	transcription nuclear factor κB
NO	nitric oxide
NT-proBNP	N-terminal pro-brain natriuretic peptide
NYHA	New York Heart Association
PD	peritoneal dialysis
RAA	renin–angiotensin–aldosterone
RAAS	renin–angiotensin–aldosterone system
RAAS-I	renin–angiotensin–aldosterone system inhibitors
RBC	red blood cells
ROS	reactive oxygen species
SCD	sudden cardiac death
SGLT2	sodium–glucose cotransporter 2
SNS	sympathetic nervous system
TGF-β	transforming growth factor β
TMAO	trimethyl amine N-oxide
TNF-α	tumor necrosis factor α
UACR	urinary albumin-to-creatinine ratio